Osiris Therapeutics (OSIR) and Jazz Pharmaceuticals (JAZZ) Critical Comparison

Osiris Therapeutics (OSIR) and Jazz Pharmaceuticals (JAZZ) Critical Comparison

Osiris Therapeutics and Jazz Pharmaceuticals are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and analyst recommendations. Osiris Therapeutics has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500.

from Biotech News